ResearcherHainan Medical UniversityNo recent work listed

Qifu Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3904-410X; OpenAlex author ID A5033851605. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest. Last author DOI 10.1002/1878-0261.12854 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ningna Weng · 1 shared paper, 2021 · strength 0.12
- Paper Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest. DOI 10.1002/1878-0261.12854 ↗
Zhe Zhang · 1 shared paper, 2021 · strength 0.12
- Paper Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest. DOI 10.1002/1878-0261.12854 ↗
Huanyu Zhang · 1 shared paper, 2021 · strength 0.12
- Paper Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest. DOI 10.1002/1878-0261.12854 ↗
Shaojiang Zheng · 1 shared paper, 2021 · strength 0.12
- Paper Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest. DOI 10.1002/1878-0261.12854 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.